All Infectious Disease articles – Page 3
-
News
Myocardial infarction may be an infectious disease
A pioneering study has demonstrated for the first time that myocardial infarction may be an infectious disease. This discovery challenges the conventional understanding of the pathogenesis of myocardial infarction and opens new avenues for treatment.
-
News
New research makes first broad-spectrum antiviral
A new study offers a promising path toward the development of the world’s first broad-spectrum antiviral (BSA), which could be deployed against a wide range of deadly viruses, including future pandemic threats.
-
News
Global Virus Network announces 2025 Rising Star Mentorship Program Awardees
The Global Virus Network (GVN) has announced the five distinguished recipients of its 2025 Rising Star Mentorship Program. The program is designed to support early-career virologists poised to become the next generation of global leaders in pandemic preparedness and infectious disease research.
-
News
Kiss goodbye to deadly disease – new research finds ‘Pac-Man’ antibodies for killer parasite
Researchers have successfully produced antibodies that kill the parasite carried by the ‘kissing bug’ that causes the potentially deadly Chagas disease. The research is a vital step towards the development of the first effective vaccine.
-
News
Researchers create faster way to trace how diseases spread indoors
Researchers have developed a new method of monitoring and tracking how disease-causing particles, or pathogens, spread from one place to another. The tool could help contain future outbreaks of diseases like COVID-19.
-
News
Global analysis reveals overlooked hotspots at risk for long COVID due to early disability burdens
An international team of researchers has conducted the most comprehensive global-to-local analysis to date on long COVID risk, using disability data from the height of the pandemic to identify vulnerable populations.
-
News
Scientists identify three potent human antibodies against mpox, paving the way for new protective therapies
Researchers have discovered three powerful monoclonal antibodies from a person who had previously been infected with mpox (formerly known as monkeypox).
-
News
New AI tool reveals how drugs kill tuberculosis
A new study offers a powerful AI-assisted method for uncovering exactly how TB drugs kill the bacteria, opening the door to smarter treatment combinations that could work faster.
-
News
Researchers use generative AI to design compounds that can kill drug-resistant bacteria
With help from artificial intelligence, researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA).
-
News
A microbial DNA signature differentiates two types of cancer in the liver
Researchers have identified a microbial DNA signature in blood plasma that reliably differentiates primary liver cancer from colorectal cancer that has spread to the liver (metastatic colorectal cancer).
-
News
‘Essentiality’ scan reveals microbe’s ‘must-have’ list
Researchers have spent years taking apart one of the world’s simplest microbes, Mycoplasma pneumoniae, piece by piece, and created a detailed list of what molecular parts the living cell can and cannot do without.
-
News
One universal antiviral to rule them all?
Taking inspiration from a rare mutation that makes people impervious to viral diseases, a researcher is developing a therapy that could bestow this superpower on the rest of us. The mutation causes a deficiency in an immune regulator called ISG15.
-
News
CRISPR-based therapeutics hold potential to combat AMR and cure chronic viral infections, says GlobalData
CRISPR-based therapeutics show potential to combat antimicrobial resistance (AMR) and deliver functional cures for chronic viral infections, says GlobalData, a leading data and analytics company.
-
News
Mount Sinai creates first manual for treating infection-associated chronic illness for clinicians
Mount Sinai has launched the country’s first clinical manual for treating infection-associated chronic illnesses (IACIs). This comprehensive guide, prepared by the Cohen Center for Recovery From Complex Chronic Illnesses, part of the Department of Rehabilitation and Human Performance, will help clinicians better diagnose and care for patients with conditions such ...
-
News
Flu fighters: researchers take a closer look at immune response to influenza
Researchers sought to identify which immune cells in pigs have receptors that are most reactive to influenza. They accomplished this by customizing a technology called single-cell RNA sequencing for pigs to learn more about how a body’s cells operate at a highly detailed level.
-
News
Broad COVID-19 vaccination makes economic sense, especially for older adults, study finds
Vaccinating every person over 65 would actually save the U.S. money, while vaccinating all younger adults would be a reasonable investment, according to a new study.
-
News
Two-dose therapy for S. aureus bloodstream infections on par with standard treatment
A clinical trial has found that the outcome of treating complicated Staphylococcus aureus bloodstream infections with two intravenous (IV) doses of the antibiotic dalbavancin seven days apart is just as good as daily IV doses of conventional antibiotics over four to six weeks.
-
News
Laser therapy enhances treatment of fungus resistant to conventional medication
Researchers have managed to reduce Candida albicans’ resistance to fungicides by incorporating photodynamic inactivation techniques into the treatment. The technology can be used in both human healthcare and the prevention of food contamination.
-
News
Study looks for markers that predict risk of severe chlamydia infection
A new study has identified markers that may predict whether a chlamydia infection is likely to ascend into the uterus and endometrium. The work could lead to new diagnostics that can predict a woman’s risk of severe infection.
-
News
As school returns, so do infections & asthma emergencies. Where kids live can make it worse
A new study highlights how neighborhood conditions shape the seasonal surge of virus-triggered asthma emergencies. It found that children in under-resourced communities face sharply higher rates of asthma flare-ups tied to viral infections during the first weeks of school.